|
|
Volumn 19 Suppl 2, Issue , 2009, Pages
|
|
Pharmacogenomics of taxane/platinum therapy in ovarian cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
PHARMACOLOGICAL BIOMARKER;
PLATINUM DERIVATIVE;
TAXOID;
TUMOR MARKER;
CARCINOMA;
DRUG EFFECT;
FEMALE;
GENE EXPRESSION REGULATION;
GENETIC VARIABILITY;
GENETICS;
HUMAN;
METHODOLOGY;
OVARY TUMOR;
PHARMACOGENETICS;
PHYSIOLOGY;
REVIEW;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOMARKERS, PHARMACOLOGICAL;
CARCINOMA;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GENETIC VARIATION;
HUMANS;
OVARIAN NEOPLASMS;
PHARMACOGENETICS;
PLATINUM COMPOUNDS;
TAXOIDS;
TUMOR MARKERS, BIOLOGICAL;
MLCS;
MLOWN;
|
|
EID: 77950355502
PISSN: None
EISSN: 15251438
Source Type: Journal
DOI: 10.1111/igc.0b013e3181c10513 Document Type: Review |
|
Times cited : (38)
|
|
References (72)
|
